Pharmacokinetic Evaluation of Intravenous Lacosamide as Short-Term Alternative to Oral Lacosamide in Partial-Onset Seizures Poster P05.182, Thursday, April 15, 2010, 7:30 am, Space 808 Objective: To investigate the pharmacokinetic parameters of IV lacosamide administered over infusion durations of 30, 15, or ten minutes while a short-term replacement for oral lacosamide in 160 patients receiving lacosamide within a long-term, open-label extension trial. 6. A Multicenter, Open-Label Trial To Measure the Security and Tolerability of a Single Intravenous Loading Dose of Lacosamide Followed by Oral Maintenance as Adjunctive Therapy in Topics with Partial-Onset Seizures: An Interim Survey Poster P05.Hoskin, D. Bottomley, N.D. James, A. Solberg, I. Syndikus, J. Kliment, S. Wedel, S. Boehmer, M. Dall’Oglio, L. Coleman, N.J. Vogelzang, C.G. O’Bryan-Tear, K. Staudacher, J. Garcia-Vargas, M.S. Bruland, and O. Sartor for the ALSYMPCA Investigators: Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer.. Advice for newly-diagnosed Parkinson’s patients After 12 years with Parkinson’s disease , 57-year old Bill Schmalfeldt has this advice for newly-diagnosed Parkinson’s patients.